Independent health informationUrgent helpHow information is checked
Evidence Health
Menu
Medicine safety

Ashwagandha for Stress and Sleep: Evidence and Safety

Pharmacist reviewing an ashwagandha supplement label with an adult
AI-generated editorial image.

Stop and seek care for possible liver injury

Stop an ashwagandha product and seek prompt medical assessment for jaundice, dark urine, pale stools, intense itching, or persistent nausea and abdominal pain. Do not use it in pregnancy. Discuss use with a clinician if you have thyroid, autoimmune, or liver disease or take sedating or immune-affecting medicines.

Regional scope: International English; US English editorial baseline. Testing, treatment and urgent-care routes can differ by country; use local services and prescribing advice.

Written byEvidence Health Editorial Team
Evidence checked2026-09-14
References3 sources
UpdatedSeptember 14, 2026
On this page

Ashwagandha is sold as a calm, sleep, and resilience shortcut. Its appeal is understandable: stress is real, and a capsule seems easier than changing work, sleep, or care. But a plant extract is a biologically active product whose composition and risks vary. The useful decision is not whether it is “natural.” It is whether the particular claimed benefit is supported, whether your health situation changes the risk, and how you would know when to stop.

The decision in brief

  • Small studies suggest possible stress and sleep effects; they do not prove broad long-term safety.
  • Products may differ in plant part, extract, concentration, and other ingredients.
  • Pregnancy, thyroid and autoimmune issues, medicines, and liver symptoms matter.
  • Do not use a stress supplement to delay care for anxiety, depression, or insomnia.
  • Set a short, measurable purpose and a stop rule before buying.

What the evidence can support

The National Center for Complementary and Integrative Health overview notes that studies have examined stress and sleep, but evidence is limited and long-term safety is not established. Different trials use different extracts and outcomes. A statistically detectable change in a questionnaire does not mean every user will sleep better or that the product treats an anxiety disorder. It also does not tell us which bottle on an online marketplace matches the studied material.

People often move from “there is some evidence for stress” to “it balances cortisol, testosterone, thyroid, immunity, and longevity.” That is a much larger claim. A marketing diagram of hormones is not a clinical outcome, and a small trial for one symptom cannot validate a whole endocrine system story. Ask the seller to identify the exact clinical outcome, studied population, duration, and formulation. If the answer is an animal study or a list of mechanisms, treat the human claim as uncertain.

What is actually in the bottle?

“Ashwagandha” can describe root preparations, leaf-containing extracts, powders, and combinations with other herbs, caffeine, magnesium, or melatonin. Extract standardization may refer to a chemical group such as withanolides, but the number on the label is not a guarantee of clinical benefit or safety. A product may contain contaminants or ingredients not apparent from marketing. Independent quality checks can reduce some uncertainty, not erase it. Read the supplement facts panel, the plant part, serving size, and every other active ingredient.

Do not compare doses between products as though they were the same drug. A gram of raw powder and a concentrated extract are not equivalent. Social-media dose escalation is especially weak reasoning when the objective is a subjective feeling of calm. If the product makes you drowsy, nauseated, wired, or unwell, increasing it because a forum promised a “loading phase” is not sensible.

Liver, thyroid, and medicine concerns

Reports of liver injury associated with ashwagandha have been described in the NIH LiverTox review. Case reports cannot establish how often injury happens across all users, but they make the warning signs important. Document the product name, ingredients, dose, and start date if symptoms arise. Stop taking it and arrange evaluation; do not try to “detox” with another supplement. Other causes of liver symptoms also need assessment.

There are also concerns about thyroid effects, immune effects, sedation, and interactions with medicines. The exact clinical impact may vary, but uncertainty is not the same as safety. The NCCIH guidance on herb–medicine interactions explains why a pharmacist needs the full product list, not just the prescription list. If you take thyroid medicine, immunosuppressants, sedatives, blood-pressure drugs, or medicines for glucose control, ask before starting. Do not stop a prescribed medicine to make room for a supplement.

Who should not run a casual home trial?

Pregnant or breastfeeding people should avoid assuming safety from tradition. People with active liver disease, unexplained abnormal liver tests, thyroid disease, autoimmune disease, a complex medicine list, or recent serious illness need individual advice. If you have severe anxiety, depression, panic, or persistent insomnia, a capsule should not replace an assessment and effective treatment. A product that dulls symptoms for a few days could delay care while the underlying problem worsens.

Children and adolescents are not small adults. Do not copy an adult wellness protocol for a child. If your goal is sleep, first consider the schedule, alcohol, caffeine, and conditions such as apnea. Our melatonin guide shows how even a familiar sleep supplement requires attention to timing and context. Adding several products at once makes benefit and adverse effects hard to attribute.

A bounded trial, if it is reasonable for you

  1. State one goal. For example, fewer nights of stress-related trouble falling asleep, not “optimal cortisol.”
  2. Check medicines and conditions. Use a pharmacist or clinician if any interactions or medical concerns apply.
  3. Choose a simple product. Avoid multi-ingredient stacks that make attribution impossible.
  4. Record the baseline. Note sleep timing, daytime function, and stress symptoms for a week.
  5. Set an end date. Decide in advance when you will reassess and stop if there is no meaningful benefit.
  6. Watch for harm. New liver symptoms, severe gastrointestinal symptoms, marked mood changes, or unusual sedation are reasons to stop and seek advice.

Do not combine the trial with a new strict diet, a new workout, and a major sleep schedule change if you want to learn anything from it. And do not interpret a falling “stress score” from a wearable as proof of endocrine healing. Ask whether you function better and whether the change is large enough to matter in daily life.

“Will it lower cortisol?” Some studies measure stress-related outcomes, but cortisol varies by time of day and circumstance. One saliva result is not a universal stress meter. A product claim that it “normalizes cortisol” needs a clear clinical outcome and safety evidence, not just a lab graph.

“Can it fix burnout?” Burnout is related to working and living conditions as well as health. A supplement cannot remove unsafe workload, sleep deprivation, or untreated mental illness. It may feel helpful to some people, but relying on it as the sole response can obscure what actually needs to change.

“Is a high dose faster?” More exposure can mean more adverse effects and is not guaranteed to improve outcomes. Different preparations make dose comparisons unreliable. A seller’s “maximum potency” is not a clinical recommendation.

“If it is sold widely, must it be safe?” Availability is not proof of quality or safety for everyone. Supplement regulation differs from medicine approval. Treat disease claims on a sales page skeptically and verify whether the product has independent quality testing.

What to discuss with a clinician

Bring the bottle or a clear photo of the full label, the start date, how often you take it, all medicines and other supplements, and the symptom you hoped to change. If you have abnormal thyroid or liver results, include the laboratory report and timing. Ask whether the product could be relevant, whether another cause should be checked, and what treatment has better evidence for your main symptom. Our lab-test guide can help you avoid turning one hormone flag into a cascade.

The best supplement decision may be to use none, to try a simple time-limited product after checking risks, or to seek formal care first. None of those choices is a failure of self-care. Ashwagandha’s strongest marketing advantage is its ability to sound like a complete answer to diffuse stress. The evidence and safety picture are narrower. Make the decision at that narrower scale.

What a convincing product trial would need

To support a strong claim, a trial would use a clearly characterized product, a comparison group, predefined outcomes that matter to patients, sufficient follow-up, and transparent adverse-event reporting. A short study of a single extract in a selected group cannot validate every root powder and multi-herb blend on the market. A seller may cite a result in healthy volunteers while advertising treatment for people with diagnosed anxiety or thyroid disease. That jump is not justified by the cited study.

Even when a trial finds a modest average benefit, individual response can vary. Some people may notice no change, and some may feel worse. An honest page should say which outcomes were actually measured and which remain uncertain. It should not call an effect “clinically proven” merely because a questionnaire score changed statistically.

Documenting a suspected adverse effect

If you become unwell, save the package and note the brand, batch number, ingredients, amount, start date, and other products used. Share these details with the clinician. They help distinguish a possible product effect from other causes and allow appropriate reporting. Do not restart the supplement to see whether symptoms recur without medical advice, particularly after liver-related symptoms. Reporting a suspected event does not require you to prove causation; it helps safety systems see patterns that a single user cannot.

Sources and evidence scope

Sources are the NCCIH ashwagandha overview, NIH LiverTox ashwagandha review, and NCCIH herb–medicine interaction guidance. Evidence is product- and population-dependent; this is not a personal safety clearance. Evidence checked September 2026.